SIRT1 and diabetes mellitus: Additionally, in a streptozotocin-induced diabetes mouse model, tetrahydrocurcumin enhanced cardiac parameters, reduced myocardial fibrosis and cardiac hypertrophy, diminished ROS generation, and elevated SIRT1 expression [122].